CClinicalTrials.gg
CompletedNCT04383132Updated Nov 12, 2020Results posted

Effectiveness of Abdominal Binder Use During Colonoscopy

An interventional study of Abdominal Binder in Performance and Tolerance of Colonoscopy, sponsored by Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital. Completed at 1 site in Turkey. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2020-11-12.

Sponsored by Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
346
Allocation
Randomized
Ages
18 Years to 90 Years
Sex
All
01

Study summary

Colonoscopy is considered the primary screening test for colorectal cancer screening worldwide. For technical difficulties previously experienced during colonoscopy, especially loop of the colonoscopy device in the colon, many solution methods have been developed and applied (manual pressure and position change, etc.). Although these methods are partially successful, there is no consensus on the optimum solution method. Few studies in the literature have investigated the use of corset during colonoscopy and conflicting results have been reported. In this study, elastic abdominal corset or false corset will be used during colonoscopy. Indeed, the investigators aim to determine whether this method is effective and safe with their own results and contribute to the literature. The primary outcome of this study will be the cecal intubation time. Secondary outcomes include manual pressure and position change during the procedure, length of cecal intubation (length of colonoscope required to reach the cecum from the anus), colonoscopy completion rate, additional anesthesia and / or analgesic requirement, patient pain and comfort level and colonoscopic findings.Efficacy will be assessed on the basis of pairwise comparisons between groups with respect to primary and secondary outcomes.

02

Conditions studied

  • Performance and Tolerance of Colonoscopy

Keywords

  • abdominal binder
  • colonoscopy
  • loop
03

In context

Lead sponsor

Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital is the lead sponsor of 38 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

Between the ages of 18 - 90 Participants must have completed the full prescribed colonoscopy purgative preparation prior to their procedure, and describe adequate cleansing.

Participants with ASA I-III (American Society of Anesthesiologists Class III)

Exclusion criteria

Exclusion Criteria:

Previous colon resection History of intra-abdominal malignancy Known anesthetic or analgesic drugs allergy Multiple planned procedures (e.g.bidirectional endoscopy) Pregnancy Active inflammatory bowel disease A history of intraabdominal malignancy History of cirrhosis or ascites Known ventral hernia

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
346 participants (actual)

Study arms

  • Experimental
    Abdominal Binder Intervention Group

    Patients randomized to Abdominal Binder Intervention Group will have the abdominal binder secured firmly between Spina iliaca anterior superior and subcostal area to the abdomen just prior the colonoscopy.

    Device: Abdominal Binder

  • Sham comparator
    Sham Group

    Sham Group will have the abdominal binder secured firmly between Spina iliaca anterior superior and subcostal area to the abdomen just prior the colonoscopy but it will be loosened just prior the procedure

    Device: Abdominal Binder

Interventions

  • DeviceAbdominal Binder

    abdominal binder is a kind of elastic abdominal compression device

06

What researchers measure

Primary outcomes

  1. Mean Cecal Intubation Time

    Cecal intubation time will be defined as the time from insertion of the colonoscope into the rectum to identification of the base of the cecum

    Time frame: During colonoscopy, from insertion of scope into rectum to point in time when base of cecum is identified,an average of 1-30 minutes

Secondary outcomes

  1. Number of Participants Who Required Ancillary Maneuvers

    Binary data indicating individually whether abdominal pressure or patient position change was used during the insertion phase of the procedure will be recorded.

    Time frame: During colonoscopy, from insertion of scope into rectum to point in time when base of cecum is identified, an average of 1-30 minutes

  2. Length of Cecal Intubation

    The length of the colonoscope required to reach the cecum from the anus will be measured

    Time frame: From inserting the scope into the rectum during the colonoscopy, until the cecum base is determined, an average of 1-30 minutes

  3. Number of Participants Who Completed the Procedure

    Dichotomous outcome indicating if the procedure was incomplete or complete.

    Time frame: During colonoscopy, from time point of insertion of scope into rectum to point in time when scope is removed from rectum,an average of 2-60 minutes

  4. Number of Participants Who Required Additional Anesthetic and / or Analgesic Drug

    Whether the patient needs an additional dose of anesthetic and / or analgesic drug to complete the colonoscopy

    Time frame: During colonoscopy, from time point of insertion of scope into rectum to point in time when scope is removed from rectum,an average of 2-60 minutes

  5. Patient Pain and Comfort Level at Discharge

    Study assistant will interview patient just prior to discharge and obtain responses for pain according to 10-point visual analog scales ( scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" =1 (min) and "worst pain"=10 (max)) and global satisfaction according to a 5-point scale ( scores are recorded by making a handwritten mark on a 5-cm line that represents a continuum between "very unsatisfied" =1 (min) and "very satisfied"=5 (max) )

    Time frame: At single time point occurring after the colonoscopy, just prior to the patient being discharged from facility,an average of 60 minutes

  6. Number of Participants According to Colonoscopy Findings

    Findings such as polyp, cancer, diverticulum detected during colonoscopy will be recorded.

    Time frame: During colonoscopy, from time point of insertion of scope into rectum to point in time when scope is removed from rectum,an average of 2-60 minutes

07

Results

Posted Nov 12, 2020

Participant flow

Participant flow — Overall Study
MilestoneAbdominal Binder Intervention GroupSham Group
Started173173
Completed173173
Not completed00

Outcome measures

PrimaryMean Cecal Intubation Time

Cecal intubation time will be defined as the time from insertion of the colonoscope into the rectum to identification of the base of the cecum

Time frame:
During colonoscopy, from insertion of scope into rectum to point in time when base of cecum is identified,an average of 1-30 minutes
Reported as:
Mean · sec
Mean Cecal Intubation Time
secAbdominal Binder Intervention GroupSham Group
Mean Cecal Intubation Time240 ± 110250 ± 115
Statistical analysis
  • Abdominal Binder Intervention Group vs Sham Group · t-test, 2 sided · p = 0.388 (Independent t-test was used to compare mean CIT between two groups. The statistical significance level was accepted as p\<0.05)
SecondaryNumber of Participants Who Required Ancillary Maneuvers

Binary data indicating individually whether abdominal pressure or patient position change was used during the insertion phase of the procedure will be recorded.

Time frame:
During colonoscopy, from insertion of scope into rectum to point in time when base of cecum is identified, an average of 1-30 minutes
Reported as:
Count of participants · Participants
Number of Participants Who Required Ancillary Maneuvers
ParticipantsAbdominal Binder Intervention GroupSham Group
Number of Participants Who Required Ancillary Maneuvers6585
Statistical analysis
  • Abdominal Binder Intervention Group vs Sham Group · Chi-squared · p = 0.069 (For the comparison of ancillary maneuvers Pearson chi-square test, Fisher's exact test, and Fisher-Freeman-Halton exact test were used.)
SecondaryLength of Cecal Intubation

The length of the colonoscope required to reach the cecum from the anus will be measured

Time frame:
From inserting the scope into the rectum during the colonoscopy, until the cecum base is determined, an average of 1-30 minutes
Reported as:
Mean · cm
Length of Cecal Intubation
cmAbdominal Binder Intervention GroupSham Group
Length of Cecal Intubation89 ± 1888.5 ± 15
Statistical analysis
  • Abdominal Binder Intervention Group vs Sham Group · t-test, 2 sided · p = 0.487 (Independent t-test was used to compare mean CIL between two groups.)
SecondaryNumber of Participants Who Completed the Procedure

Dichotomous outcome indicating if the procedure was incomplete or complete.

Time frame:
During colonoscopy, from time point of insertion of scope into rectum to point in time when scope is removed from rectum,an average of 2-60 minutes
Reported as:
Count of participants · Participants
Number of Participants Who Completed the Procedure
ParticipantsAbdominal Binder Intervention GroupSham Group
Number of Participants Who Completed the Procedure169168
Statistical analysis
  • Abdominal Binder Intervention Group vs Sham Group · Chi-squared · p = 0.822
SecondaryNumber of Participants Who Required Additional Anesthetic and / or Analgesic Drug

Whether the patient needs an additional dose of anesthetic and / or analgesic drug to complete the colonoscopy

Time frame:
During colonoscopy, from time point of insertion of scope into rectum to point in time when scope is removed from rectum,an average of 2-60 minutes
Reported as:
Count of participants · Participants
Number of Participants Who Required Additional Anesthetic and / or Analgesic Drug
ParticipantsAbdominal Binder Intervention GroupSham Group
Number of Participants Who Required Additional Anesthetic and / or Analgesic Drug4364
Statistical analysis
  • Abdominal Binder Intervention Group vs Sham Group · Chi-squared · p = 0.016
SecondaryPatient Pain and Comfort Level at Discharge

Study assistant will interview patient just prior to discharge and obtain responses for pain according to 10-point visual analog scales ( scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" =1 (min) and "worst pain"=10 (max)) and global satisfaction according to a 5-point scale ( scores are recorded by making a handwritten mark on a 5-cm line that represents a continuum between "very unsatisfied" =1 (min) and "very satisfied"=5 (max) )

Time frame:
At single time point occurring after the colonoscopy, just prior to the patient being discharged from facility,an average of 60 minutes
Reported as:
Mean · score on a scale
Patient Pain and Comfort Level at Discharge
score on a scaleAbdominal Binder Intervention GroupSham Group
VAS score1.9 ± 1.63.3 ± 1.8
patient satisfaction score1.7 ± 0.91.7 ± 0.9
Statistical analysis
  • Abdominal Binder Intervention Group vs Sham Group · t-test, 2 sided · p = 0.001
SecondaryNumber of Participants According to Colonoscopy Findings

Findings such as polyp, cancer, diverticulum detected during colonoscopy will be recorded.

Time frame:
During colonoscopy, from time point of insertion of scope into rectum to point in time when scope is removed from rectum,an average of 2-60 minutes
Reported as:
Count of participants · Participants
Number of Participants According to Colonoscopy Findings
ParticipantsAbdominal Binder Intervention GroupSham Group
Polyps7270
Diverticulosis6059
No mucosal pathology3842
IBD or colitis02
colon cancer30
Statistical analysis
  • Abdominal Binder Intervention Group vs Sham Group · Fisher Exact · p = 0.184

Adverse events

Collected over Time from the start of the colonoscopy until the patient's discharge, approximately 1-2 hours. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Abdominal Binder Intervention Group0/173 (0%)0/173 (0%)0/173 (0%)
Sham Group0/173 (0%)0/173 (0%)0/173 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Abdominal Binder Intervention GroupSham GroupTotal
Mean50.53 ± 12.352.57 ± 12.4151.55 ± 12.38
Sex: Female, Male
Sex: Female, Male(Participants)Abdominal Binder Intervention GroupSham GroupTotal
Female97108205
Male7665141
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Abdominal Binder Intervention GroupSham GroupTotal
Count of participants——0
Region of Enrollment
Region of Enrollment(Participants)Abdominal Binder Intervention GroupSham GroupTotal
Turkey173173346
Body Mass Index (BMI)
Body Mass Index (BMI)(kg/m^2)Abdominal Binder Intervention GroupSham GroupTotal
Mean28.79 ± 5.0229.62 ± 5.5429.2 ± 5.3
waist circumference (WC)
waist circumference (WC)(cm)Abdominal Binder Intervention GroupSham GroupTotal
Mean102.33 ± 10.67103.26 ± 11.84102.8 ± 11.27
08

Study locations

1 site
  • Martyr Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital
    İstanbul, 34785, Turkey
09

References and documents

Study documents

  • Protocol, analysis plan and consent form · Apr 19, 2020

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — all IPD that underlie results in a publication

Supporting information: Study protocol, Icf, Csr

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 12, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04383132
Lead sponsor
Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital
Responsible party
Beslen Goksoy (Principal Investigator, Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital) — Principal investigator
First posted
May 12, 2020
Start date
May 15, 2020
Primary completion
Aug 15, 2020
Completion
Aug 15, 2020
Results posted
Nov 12, 2020
Last update
Nov 12, 2020

Study contacts

Beslen Göksoy, M.D.
principal investigator · Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion